Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
57.10
-2.62 (-4.39%)
At close: Aug 14, 2026
-33.07% (1Y)
| Market Cap | 3.81B -32.6% |
| Revenue (ttm) | 373.49M +26.6% |
| Net Income | 109.68M +24.5% |
| EPS | 1.64 +23.4% |
| Shares Out | 66.70M |
| PE Ratio | 34.81 |
| Forward PE | n/a |
| Dividend | 0.70 (1.17%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 1,906,589 |
| Open | 59.04 |
| Previous Close | 59.72 |
| Day's Range | 57.01 - 59.52 |
| 52-Week Range | 44.88 - 92.00 |
| Beta | -0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |